Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
doi:10.2174/157015909787602788 Kappos L, Gold R, Miller DH, Macmanus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Yang M, Eraksoy M, Meluzinova E, Rektor I, Dawson KT, Sandrock AW, ONeil GN, BG-12 Phase IIb Study Investigators (2008) Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
87 OhnishiS.SaitoH.FukadaA.InuiK
Chorna, I.V
He saw telehealth become the new normal with the COVID-19 pandemic and now it's holding on and spreading even further since the last stay-at-home order was lifted
A large epidemiological study involving 3,751 patients with both IBD and T2DM compared various antidiabetic treatments
